DiagnaMed Launches New Healthcare Provider Network Program for CERVAI™ Brain Health AI Platform in Canada and the USA
TORONTO, Oct. 03, 2023 (GLOBE NEWSWIRE) — DiagnaMed Holdings Corp. (“DiagnaMed” or the “Company”) (CSE: DMED) (OTCQB:DGNMF), a generative artificial intelligence healthcare company, announced today the launch of CERVAI™ Healthcare Provider Network, a partnership program to expand access to the Company’s brain health AI platform for healthcare providers, including hospitals, doctor offices, medical clinics, research and clinical specialists in Canada and the USA.
Related news for (DGNMF)
- DiagnaMed Offering its Brain Health AI Platform for Investigating Weight Loss Drugs, such as Semaglutide (GLP-1), on Brain Function
- DiagnaMed Cancels Previously Announced Private Placement
- DiagnaMed Announces LIFE Offering of up to $650,000
- DiagnaMed Announces Canadian Launch of BRAIN AGE® Brain Health AI
- DiagnaMed Adds New Launch Site of CERVAI™ Brain Health AI